lorazepam / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   33 Trials   33 Trials   2235 News 


«12...25262728293031323334353637»
  • ||||||||||  OxiFast (oxycodone immediate release) / Purdue, Shionogi, Mundipharma
    New P4 trial:  OSDI: Oral Sedation During Cervical Dilator Placement (clinicaltrials.gov) -  Jun 27, 2017   
    P4,  N=60, Not yet recruiting, 
  • ||||||||||  ketamine / Generic mfg.
    Trial primary completion date:  Treatment Resistant Depression (Pilot) (clinicaltrials.gov) -  May 30, 2017   
    P=N/A,  N=40, Recruiting, 
    Phase classification: P=N/A --> P1 | N=30 --> 6 | Active, not recruiting --> Terminated; poor recruitment Trial primary completion date: Jun 2016 --> Jun 2018
  • ||||||||||  lorazepam / Generic mfg., diazepam / Generic mfg., alprazolam / Generic mfg.
    Trial initiation date:  Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) (clinicaltrials.gov) -  May 16, 2017   
    P1,  N=480, Not yet recruiting, 
    Trial primary completion date: Jun 2016 --> Jun 2018 Initiation date: May 2017 --> Sep 2017
  • ||||||||||  lorazepam / Generic mfg., ibuprofen / Generic mfg.
    Trial primary completion date:  Analgesia for Endometrial Scratching (clinicaltrials.gov) -  May 9, 2017   
    P=N/A,  N=150, Enrolling by invitation, 
    Initiation date: May 2017 --> Sep 2017 Trial primary completion date: Mar 2017 --> Sep 2017
  • ||||||||||  Recentin (cediranib) / AstraZeneca
    Trial primary completion date, Monotherapy, Metastases:  Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) -  May 4, 2017   
    P2,  N=70, Recruiting, 
    Trial primary completion date: Mar 2017 --> Sep 2017 Trial primary completion date: Apr 2017 --> Apr 2018
  • ||||||||||  lorazepam / Generic mfg., haloperidol / Generic mfg.
    Trial primary completion date, Metastases:  Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (clinicaltrials.gov) -  Mar 30, 2017   
    P2,  N=93, Active, not recruiting, 
    Trial primary completion date: Mar 2017 --> Dec 2015 Trial primary completion date: Jan 2018 --> Jan 2019
  • ||||||||||  darigabat (CVL-865) / Cerevel Therap
    Trial completion:  PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) -  Mar 14, 2017   
    P2,  N=7, Completed, 
    Trial primary completion date: Jan 2018 --> Jan 2019 Recruiting --> Completed
  • ||||||||||  gabapentin / Generic mfg.
    Enrollment open:  Gabapentin for Alcohol Withdrawal Syndrome (clinicaltrials.gov) -  Feb 16, 2017   
    P4,  N=400, Recruiting, 
    Recruiting --> Completed Not yet recruiting --> Recruiting
  • ||||||||||  Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
    Trial completion:  Biological Basis of Individual Variation in Social Cooperation (clinicaltrials.gov) -  Dec 14, 2016   
    P=N/A,  N=625, Completed, 
    Not yet recruiting --> Recruiting Active, not recruiting --> Completed
  • ||||||||||  Onsolis (BEMA fentanyl) / Viatris, Collegium Pharma
    Enrollment closed:  Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) (clinicaltrials.gov) -  Nov 15, 2016   
    P1,  N=109, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: Apr 2017 --> Aug 2016 Recruiting --> Active, not recruiting
  • ||||||||||  Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
    Enrollment closed:  Biological Basis of Individual Variation in Social Cooperation (clinicaltrials.gov) -  Oct 10, 2016   
    P=N/A,  N=750, Active, not recruiting, 
    Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
  • ||||||||||  lorazepam / Generic mfg., haloperidol / Generic mfg.
    Enrollment closed, Enrollment change, Metastases:  Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (clinicaltrials.gov) -  Sep 16, 2016   
    P2,  N=93, Active, not recruiting, 
    Trial primary completion date: Oct 2016 --> Jan 2017 Recruiting --> Active, not recruiting | N=60 --> 93
  • ||||||||||  lorazepam / Generic mfg., topiramate / Generic mfg.
    Trial completion, Trial primary completion date:  Characterizing and Predicting Drug Effects on Cognition (clinicaltrials.gov) -  Sep 15, 2016   
    P4,  N=78, Completed, 
    Recruiting --> Active, not recruiting | N=60 --> 93 Recruiting --> Completed | Trial primary completion date: May 2017 --> Aug 2016
  • ||||||||||  ondansetron intravenous / Generic mfg., lorazepam / Generic mfg., diazepam / Generic mfg.
    Trial completion, Trial primary completion date:  Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients (clinicaltrials.gov) -  Sep 8, 2016   
    P=N/A,  N=26, Completed, 
    Recruiting --> Completed | Trial primary completion date: May 2017 --> Aug 2016 Enrolling by invitation --> Completed | Trial primary completion date: Mar 2013 --> Dec 2010
  • ||||||||||  lorazepam / Generic mfg., ibuprofen / Generic mfg.
    New trial:  Analgesia for Endometrial Scratching (clinicaltrials.gov) -  Aug 11, 2016   
    P=N/A,  N=150, Enrolling by invitation, 
  • ||||||||||  Syntocinon Nasal Spray (oxytocin intranasal) / Vyera Pharma
    Trial primary completion date:  Biological Basis of Individual Variation in Social Cooperation (clinicaltrials.gov) -  Jul 19, 2016   
    P=N/A,  N=750, Enrolling by invitation, 
    Recruiting --> Completed Trial primary completion date: Jun 2016 --> Sep 2016
  • ||||||||||  lorazepam / Generic mfg.
    Trial completion:  Lorazepam for the Treatment of Status Epilepticus in Children (clinicaltrials.gov) -  May 21, 2016   
    P1,  N=69, Completed, 
    Trial primary completion date: Jul 2016 --> Apr 2017 Recruiting --> Completed
  • ||||||||||  lorazepam / Generic mfg., midazolam hydrochloride / Generic mfg.
    Trial completion:  Lorazepam Sedation for Critically Ill Children (clinicaltrials.gov) -  May 21, 2016   
    P2/3,  N=179, Completed, 
    Recruiting --> Completed Suspended --> Completed
  • ||||||||||  Recentin (cediranib) / AstraZeneca
    Trial primary completion date, Monotherapy, Metastases:  Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) -  Mar 5, 2016   
    P2,  N=70, Recruiting, 
    N=200 --> 30 Trial primary completion date: Apr 2016 --> Apr 2017
  • ||||||||||  darigabat (CVL-865) / Cerevel Therap
    Trial primary completion date:  PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) -  Feb 23, 2016   
    P2,  N=8, Recruiting, 
    Trial primary completion date: Apr 2016 --> Apr 2017 Trial primary completion date: Jul 2016 --> Nov 2016
  • ||||||||||  lorazepam / Generic mfg., haloperidol / Generic mfg.
    Enrollment change, Trial primary completion date, Metastases:  Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (clinicaltrials.gov) -  Feb 17, 2016   
    P2,  N=60, Recruiting, 
    Trial primary completion date: Jul 2016 --> Nov 2016 N=34 --> 60 | Trial primary completion date: Jan 2017 --> Jan 2018
  • ||||||||||  darigabat (CVL-865) / Cerevel Therap
    Enrollment open:  PF-06372865 in Subjects With Photosensitive Epilepsy (clinicaltrials.gov) -  Feb 12, 2016   
    P2,  N=8, Recruiting, 
    N=34 --> 60 | Trial primary completion date: Jan 2017 --> Jan 2018 Not yet recruiting --> Recruiting
  • ||||||||||  Onsolis (BEMA fentanyl) / Viatris, Collegium Pharma
    Trial primary completion date:  Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) (clinicaltrials.gov) -  Jan 30, 2016   
    P1,  N=100, Recruiting, 
    N=150 --> 49 | Recruiting --> Terminated; DSMB recommendation for slow enrollment Trial primary completion date: Apr 2016 --> Apr 2017
  • ||||||||||  ketamine / Generic mfg.
    Trial primary completion date:  Treatment Resistant Depression (Pilot) (clinicaltrials.gov) -  Nov 19, 2015   
    P=N/A,  N=40, Recruiting, 
    Trial primary completion date: Oct 2015 --> Sep 2016 Trial primary completion date: Dec 2015 --> Jun 2016
  • ||||||||||  Gralise (gabapentin) / Alvogen
    Enrollment closed, Trial primary completion date:  Stanford Accelerated Recovery Trial (START) (clinicaltrials.gov) -  Aug 26, 2015   
    P3,  N=560, Active, not recruiting, 
    Trial primary completion date: Dec 2015 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Jul 2016